Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Feng Zhou

Showing results (1-10 of 316) with videos related to

Pageof 32
Sort By:
Current Drug Metabolism|May 14, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4Shu-Feng Zhou
Clinical Pharmacokinetics|October 13, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part IShu-Feng Zhou
The New England Journal of Medicine|June 19, 2007
ERCC1 and non-small-cell lung cancerShu-Feng Zhou
Clinical Pharmacokinetics|November 12, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part IIShu-Feng Zhou
Drug Design, Development and Therapy|August 1, 2015
Functional magnetic resonance imaging is a powerful approach to probing the mechanism of action of therapeutic drugs that act on the central nervous systemShu-Feng Zhou
Current Pharmaceutical Design|May 14, 2008
Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4Shu-Feng Zhou
Journal of Alternative and Complementary Medicine (New York, N.Y.)|May 30, 2007
HLA polymorphisms and genetic markers for traditional Chinese medicineShu-Feng Zhou
Current Drug Metabolism|June 10, 2008
An update on clinical drug interactions with the herbal antidepressant St. John's wortShu-Feng Zhou, Xinsheng Lai
Current Medicinal Chemistry|September 17, 2009
Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug developmentBo Wang, Shu-Feng Zhou
Molecules (Basel, Switzerland)|February 18, 2017
Drug Design and Discovery: Principles and ApplicationsShu-Feng Zhou, Wei-Zhu Zhong
Pageof 32

Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Current Drug Metabolism|May 14, 2008
Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4Shu-Feng Zhou
Clinical Pharmacokinetics|October 13, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part IShu-Feng Zhou
The New England Journal of Medicine|June 19, 2007
ERCC1 and non-small-cell lung cancerShu-Feng Zhou
Clinical Pharmacokinetics|November 12, 2009
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part IIShu-Feng Zhou
Drug Design, Development and Therapy|August 1, 2015
Functional magnetic resonance imaging is a powerful approach to probing the mechanism of action of therapeutic drugs that act on the central nervous systemShu-Feng Zhou
Current Pharmaceutical Design|May 14, 2008
Potential strategies for minimizing mechanism-based inhibition of cytochrome P450 3A4Shu-Feng Zhou
Journal of Alternative and Complementary Medicine (New York, N.Y.)|May 30, 2007
HLA polymorphisms and genetic markers for traditional Chinese medicineShu-Feng Zhou
Current Drug Metabolism|June 10, 2008
An update on clinical drug interactions with the herbal antidepressant St. John's wortShu-Feng Zhou, Xinsheng Lai
Current Medicinal Chemistry|September 17, 2009
Synthetic and natural compounds that interact with human cytochrome P450 1A2 and implications in drug developmentBo Wang, Shu-Feng Zhou
Molecules (Basel, Switzerland)|February 18, 2017
Drug Design and Discovery: Principles and ApplicationsShu-Feng Zhou, Wei-Zhu Zhong
Pageof 32